O'Brien Patrick bought ARWR
January 4, 2025 · Form 4 insider transaction
O'Brien Patrick bought 100,000 shares of Arrowhead Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
100,000
Price
$0.00
Total value
N/A
InsiderO'Brien Patrick
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 4, 2025
Filing dateJanuary 7, 2025
Shares owned after564,385
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares underlying restricted stock units with a grant date 01/04/2025, which will vest in four equal annual installments.